Status:
COMPLETED
Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
The low grade glioma (LGG) is a type of brain tumor which is generally more common in younger age group patients. Most patients with LGG undergo surgery which is mostly incomplete due to concern about...
Detailed Description
Summary: Comprehensive analysis of the angiogenesis-related gene expression profiles and tumor perfusion of patients with LGG will provide a novel understanding of subgroup (low and high-risk) of LGG....
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Greater than 18 years of age
- Brain tumor with no contrast enhancement on conventional MRI and confirmed histological of LGG
- No adjustment treatment
- Consent to participate in study
- No contra-indication for dynamic contrast-enhanced (DCE)-MRI
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00137488
Start Date
November 1 2005
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2